LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX)

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COMMON STOCK
Shares outstanding
363,214,619
Total 13F shares
102,423,092
Share change
-2,759,358
Total reported value
$308,322,526
Put/Call ratio
127%
Price per share
$3.01
Number of holders
95
Value change
-$29,982,037
Number of buys
38
Number of sells
49

Institutional Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q3 2019

As of 30 Sep 2019, LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) was held by 95 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 102,423,092 shares. The largest 10 holders included Artal Group S.A., FMR LLC, Ulys, L.L.C., BlackRock Inc., VANGUARD GROUP INC, BOXER CAPITAL, LLC, NEA Management Company, LLC, MILLENNIUM MANAGEMENT LLC, UBS ASSET MANAGEMENT AMERICAS INC, and STATE STREET CORP. This page lists 95 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.